NEUE NeueHealth
- 7.390
- +0.030+0.41%
NeueHealth News
NeueHealth Is Maintained at Sector Perform by RBC Capital
NeueHealth Analyst Ratings
RBC Capital Maintains NeueHealth(NEUE.US) With Hold Rating, Cuts Target Price to $7
RBC Lowers Price Target on NeueHealth to $7 From $8, Keeps Sector Perform Rating
Analysts Conflicted on These Healthcare Names: NeueHealth Inc (NEUE), Agilent (A) and Legend Biotech (LEGN)
Analysts Conflicted on These Healthcare Names: NeueHealth Inc (NEUE), BridgeBio Pharma (BBIO) and Biohaven Ltd. (BHVN)
RBC Capital Sticks to Their Hold Rating for NeueHealth Inc (NEUE)
NeueHealth Analyst Ratings
RBC Capital Sticks to Their Hold Rating for NeueHealth Inc (NEUE)
Analysts Offer Insights on Healthcare Companies: Cencora (COR), Cormedix (CRMD) and NeueHealth Inc (NEUE)
Analyst Ratings for Bright Health Gr
Morgan Stanley Maintains Underweight on Bright Health Gr, Lowers Price Target to $8
Bright Health Gr Analyst Ratings
RBC Capital Maintains Sector Perform on Bright Health Gr, Raises Price Target to $16
Bright Health Gr Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioNTech SE (BNTX) and Bright Health Group (BHG)
Bright Health Group (BHG) Gets a Sell From Barclays
Analysts Conflicted on These Healthcare Names: Relay Therapeutics (RLAY), Bright Health Group (BHG) and Bausch + Lomb Corporation (BLCO)
Nephron Research Upgrades Bright Health Gr to Buy, Announces $85 Price Target
Barclays Downgrades Bright Health Gr to Underweight, Raises Price Target to $8
No Data